Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 108 articles:
HTML format



Single Articles


    July 2021
  1. ZHAO B, Bouchareb R, Lebeche D
    Resistin deletion protects against heart failure injury by targeting DNA damage response.
    Cardiovasc Res. 2021 Jul 29. pii: 6330773. doi: 10.1093.
    PubMed     Abstract available


  2. ABDELLATIF M, Lam CSP
    Scientists on the Spot: A fraction of wisdom on heart failure.
    Cardiovasc Res. 2021;117:e114-e115.
    PubMed    


  3. MARKOUSIS-MAVROGENIS G, Tromp J, Ouwerkerk W, Fereirra JP, et al
    Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF.
    Cardiovasc Res. 2021 Jul 15. pii: 6321950. doi: 10.1093.
    PubMed     Abstract available


  4. DIEZ J, de Boer RA
    Management of cardiac fibrosis is the largest unmet medical need in heart failure Cardiac fibrosis in heart failure.
    Cardiovasc Res. 2021 Jul 9. pii: 6318397. doi: 10.1093.
    PubMed     Abstract available


  5. GRASSI G, Mancia G, Esler M
    CENTRAL AND PERIPHERAL SYMPATHETIC ACTIVATION IN HEART FAILURE.
    Cardiovasc Res. 2021 Jul 7. pii: 6317668. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  6. ONODI Z, Ruppert M, Kucsera D, Sayour AA, et al
    AIM2-driven inflammasome activation in heart failure.
    Cardiovasc Res. 2021 Jun 12. pii: 6297397. doi: 10.1093.
    PubMed     Abstract available


  7. SANSONETTI M, De Windt LJ
    Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure.
    Cardiovasc Res. 2021 Jun 7. pii: 6294284. doi: 10.1093.
    PubMed     Abstract available


  8. NAUMENKO N, Mutikainen M, Holappa L, Ruas JL, et al
    PGC-1alpha deficiency reveals sex-specific links between cardiac energy metabolism and EC-coupling during development of heart failure in mice.
    Cardiovasc Res. 2021 Jun 4. pii: 6292089. doi: 10.1093.
    PubMed     Abstract available


    May 2021

  9. Corrigendum to: Heart failure or heart success?
    Cardiovasc Res. 2021 May 18. pii: 6277376. doi: 10.1093.
    PubMed    


    April 2021

  10. Retraction: Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure.
    Cardiovasc Res. 2021 Apr 22. pii: 6245632. doi: 10.1093.
    PubMed    


  11. BOLLI R, Solankhi M, Tang XL, Kahlon A, et al
    Cell Therapy in Patients with Heart Failure: A Comprehensive Review and Emerging Concepts.
    Cardiovasc Res. 2021 Apr 19. pii: 6237881. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  12. KARWI QG, Ho KL, Pherwani S, Ketema EB, et al
    Concurrent diabetes and heart failure: interplay and novel therapeutic approaches.
    Cardiovasc Res. 2021 Mar 30. pii: 6203809. doi: 10.1093.
    PubMed     Abstract available


  13. TAKAHARA S, Soni S, Maayah ZH, Ferdaoussi M, et al
    Ketone Therapy for Heart Failure: Current Evidence for Clinical Use.
    Cardiovasc Res. 2021 Mar 10. pii: 6168424. doi: 10.1093.
    PubMed     Abstract available


  14. CUOMO A, Pirozzi F, Tocchetti CG
    Low-intensity pulsed ultrasound (LIPUS) in heart failure with preserved ejection fraction (HFpEF): lupus in fabula?
    Cardiovasc Res. 2021 Mar 5. pii: 6159769. doi: 10.1093.
    PubMed    


    February 2021
  15. LUXAN G, Dimmeler S
    The vasculature: a therapeutic target in heart failure?
    Cardiovasc Res. 2021 Feb 23. pii: 6146925. doi: 10.1093.
    PubMed     Abstract available


  16. TERAMOTO K, Tromp J, Lam CSP
    Heart failure or heart success?
    Cardiovasc Res. 2021 Feb 13. pii: 6134544. doi: 10.1093.
    PubMed    


  17. DE LUCIA C, Grisanti LA, Borghetti G, Piedepalumbo M, et al
    GRK5 contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
    Cardiovasc Res. 2021 Feb 9. pii: 6131786. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  18. HEGYI B, Ko CY, Bossuyt J, Bers DM, et al
    Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycemia: reduced repolarization reserve, neurohormonal stimulation and heart failure exacerbate susceptibility.
    Cardiovasc Res. 2021 Jan 23. pii: 6105172. doi: 10.1093.
    PubMed     Abstract available


  19. CICCARELLI M, Dawson D, Falcao-Pires I, Giacca M, et al
    Reciprocal organ interactions during heart failure-a position paper from the ESC working group on myocardial function.
    Cardiovasc Res. 2021 Jan 22. pii: 6105178. doi: 10.1093.
    PubMed     Abstract available


  20. TOENNIS T, Kirchhof P
    Connecting the dots? Rate control, heart failure, and atrial fibrillation.
    Cardiovasc Res. 2021;117:336-337.
    PubMed    


  21. PANENI F, Sciarretta S, Costantino S
    Tackling myocardial oxidative stress with empagliflozin: are we big enough to fight heart failure with preserved ejection fraction?
    Cardiovasc Res. 2021;117:343-345.
    PubMed    


    November 2020
  22. MELI AC, Fischmeister R
    Scientists on the spot: Phosphodiesterases and heart failure.
    Cardiovasc Res. 2020 Nov 1. pii: 5952729. doi: 10.1093.
    PubMed    


    October 2020
  23. NAKAMURA M, Odanovic N, Nakada Y, Dohi S, et al
    Dietary Carbohydrates Restriction Inhibits The Development Of Cardiac Hypertrophy And Heart Failure.
    Cardiovasc Res. 2020 Oct 18. pii: 5929700. doi: 10.1093.
    PubMed     Abstract available


  24. PANICO C, Kallikourdis M, Condorelli G
    Defining circulating mononuclear cells in heart failure through single-cell RNA sequencing: new insights for an old disease.
    Cardiovasc Res. 2020 Oct 13. pii: 5922371. doi: 10.1093.
    PubMed    


  25. LANG NN, Dobbin SJH, Petrie MC
    Vericiguat in worsening heart failure: agonising over, or celebrating, agonism in the VICTORIA trial.
    Cardiovasc Res. 2020;116:e152-e155.
    PubMed    


    September 2020
  26. WITHAAR C, Meems LMG, Markousis-Mavrogenis G, Boogerd CJ, et al
    The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of Heart Failure with Preserved Ejection Fraction.
    Cardiovasc Res. 2020 Sep 1. pii: 5900261. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  27. PERROTTA S, Carnevale D
    A neuro-humoral activation of RAAS in endothelial dysfunction modulating immunity in heart failure.
    Cardiovasc Res. 2020 Aug 4. pii: 5880579. doi: 10.1093.
    PubMed    


  28. BERTERO E, Stork S, Maack C
    REPORT-HF reveals global inequalities in health care provision and prognosis of patients with acute heart failure.
    Cardiovasc Res. 2020;116:e112-e114.
    PubMed    


    July 2020
  29. NAGUEH SF
    Heart Failure with Preserved Ejection Fraction: Insights into Diagnosis and Pathophysiology.
    Cardiovasc Res. 2020 Jul 27. pii: 5876832. doi: 10.1093.
    PubMed     Abstract available


  30. SCHIATTARELLA GG, Rodolico D, Hill JA
    Metabolic Inflammation in Heart Failure with Preserved Ejection Fraction.
    Cardiovasc Res. 2020 Jul 14. pii: 5871499. doi: 10.1093.
    PubMed     Abstract available


  31. MELI AC, de Tombe P
    Scientists on the Spot: Myocardium and myofilaments.
    Cardiovasc Res. 2020;116:e96-e97.
    PubMed    


    May 2020
  32. KOLIJN D, Pabel S, Tian Y, Lodi M, et al
    Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Galpha oxidation.
    Cardiovasc Res. 2020 May 12. pii: 5836298. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  33. ABPLANALP WT, John D, Cremer S, Assmus B, et al
    Single cell RNA sequencing reveals profound changes in circulating immune cells in patients with heart failure.
    Cardiovasc Res. 2020 Apr 20. pii: 5822866. doi: 10.1093.
    PubMed     Abstract available


  34. PACKER M
    Critical Examination of Mechanisms Underlying the Reduction in Heart Failure Events With SGLT2 Inhibitors: Identification of a Molecular Link Between Their Actions to Stimulate Erythrocytosis and to Alleviate Cellular Stress.
    Cardiovasc Res. 2020 Apr 3. pii: 5815560. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  35. RADEMAKER MT, Scott NJA, Koh CY, Kini RM, et al
    Natriuretic peptide analogues with distinct vasodilatory or renal activity: Integrated effects in health and experimental heart failure.
    Cardiovasc Res. 2020 Mar 13. pii: 5804984. doi: 10.1093.
    PubMed     Abstract available


  36. VAN BERLO JH, Garry DJ
    Hearts and Hands: the good, the bad, and the ugly.
    Cardiovasc Res. 2020;116:470-472.
    PubMed    


  37. VOLLAND C, Schott P, Didie M, Manner J, et al
    Control of p21Cip by BRCA1-associated protein is critical for cardiomyocyte cell cycle progression and survival.
    Cardiovasc Res. 2020;116:592-604.
    PubMed     Abstract available


    February 2020
  38. MOLITOR M, Rudi WS, Garlapati V, Finger S, et al
    Nox2+ Myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
    Cardiovasc Res. 2020 Feb 20. pii: 5741408. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  39. CAMICI PG, Tschope C, Carli MFD, Rimoldi O, et al
    Coronary microvascular dysfunction in hypertrophy and heart failure.
    Cardiovasc Res. 2020 Jan 30. pii: 5718012. doi: 10.1093.
    PubMed     Abstract available


  40. ZHANG D, Tu H, Wang C, Cao L, et al
    Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure.
    Cardiovasc Res. 2020 Jan 29. pii: 5717428. doi: 10.1093.
    PubMed     Abstract available


  41. VERMA S
    The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fraction.
    Cardiovasc Res. 2020;116:e8-e10.
    PubMed    


  42. COHEN-SOLAL A, Logeart D
    Is the glass half full or half empty after PARAGON-HF?
    Cardiovasc Res. 2020;116:e5-e7.
    PubMed    


  43. CHEN MP, Kiduko SA, Saad NS, Canan BD, et al
    Stretching single titin molecules from failing human hearts reveals titin's role in blunting cardiac kinetic reserve.
    Cardiovasc Res. 2020;116:127-137.
    PubMed     Abstract available


    November 2019
  44. FILIPPATOS G, Farmakis D
    A look back: the quest for thrombosis in heart failure continues after COMMANDER HF.
    Cardiovasc Res. 2019;115:e140-e142.
    PubMed    


    October 2019
  45. SACK MN
    The Enigma of Anti-Inflammatory Therapy for the Management of Heart Failure.
    Cardiovasc Res. 2019 Oct 30. pii: 5610071. doi: 10.1093.
    PubMed    


  46. BILCHICK K, Kothari H, Narayan A, Garmey J, et al
    Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1beta in heart failure.
    Cardiovasc Res. 2019 Oct 15. pii: 5585796. doi: 10.1093.
    PubMed     Abstract available


  47. ANTONIADES C, Condorelli G
    Scientists on the Spot: non-coding RNAs and heart failure.
    Cardiovasc Res. 2019 Oct 9. pii: 5584268. doi: 10.1093.
    PubMed    


    September 2019
  48. DOCHERTY KF, McMurray JJV
    PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction.
    Cardiovasc Res. 2019 Sep 8. pii: 5565262. doi: 10.1093.
    PubMed    


    August 2019
  49. SOBANSKI PZ, Alt-Epping B, Currow DC, Goodlin SJ, et al
    Palliative Care for people living with heart failure - European Association for Palliative Care Task Force expert position statement.
    Cardiovasc Res. 2019 Aug 6. pii: 5544269. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  50. PELLICORI P, Zhang J, Cuthbert J, Urbinati A, et al
    High sensitivity C-Reactive Protein in Chronic Heart Failure: Patient Characteristics, Phenotypes and Mode of Death.
    Cardiovasc Res. 2019 Jul 26. pii: 5539697. doi: 10.1093.
    PubMed     Abstract available


  51. FIRULLI BA, George R, Harkin J, Toolan KP, et al
    HAND1 loss-of-function within the embryonic myocardium reveals survivable congenital cardiac defects and adult heart failure.
    Cardiovasc Res. 2019 Jul 9. pii: 5529958. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  52. RIEHLE C, Bauersachs J
    Small Animal Models of Heart Failure.
    Cardiovasc Res. 2019 Jun 27. pii: 5523845. doi: 10.1093.
    PubMed     Abstract available


  53. BERTERO E, Maack C
    The Partial AdeNosine A1 receptor agonist in patients with Chronic Heart failure and preserved Ejection fraction (PANACHE) trial.
    Cardiovasc Res. 2019 Jun 10. pii: 5513228. doi: 10.1093.
    PubMed    


    May 2019
  54. KONEMANN S, Sartori LV, Gross S, Hadlich S, et al
    Cardio-protective effect of the secretome of Sca-1+ and Sca-1- cells in heart failure - not equal, but equally important?
    Cardiovasc Res. 2019 May 22. pii: 5497483. doi: 10.1093.
    PubMed     Abstract available


  55. KONDO H, Takahashi N
    Reduced hospitalization for heart failure using anti-diabetic drug dapagliflozin: implications of DECLARE-TIMI 58 for the basic science community.
    Cardiovasc Res. 2019;115:e54-e57.
    PubMed    


    March 2019
  56. ESFANDIARY A, Kutsche H, Schreckenberg R, Weber M, et al
    Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing.
    Cardiovasc Res. 2019 Mar 8. pii: 5372345. doi: 10.1093.
    PubMed     Abstract available


  57. DE KLEIJN DPV, Chong SY, Wang X, Yatim SMJM, et al
    Toll-like Receptor 7 Deficiency Promotes Survival and Reduces Adverse Left Ventricular Remodeling After Myocardial Infarction.
    Cardiovasc Res. 2019 Mar 4. pii: 5369232. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  58. NGUYEN QT, Jalloul Nsaibia M, Sirois MG, Calderone A, et al
    PBI-4050 Reduces Pulmonary Hypertension, Lung fibrosis and Right Ventricular Dysfunction in Heart Failure.
    Cardiovasc Res. 2019 Feb 7. pii: 5308607. doi: 10.1093.
    PubMed     Abstract available


  59. MEIJERS WC, de Boer RA
    Common risk factors for heart failure and cancer.
    Cardiovasc Res. 2019 Feb 4. pii: 5306334. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  60. ENDOH M
    SERCA in heterogeneity of diastolic dysfunction in post-infarction heart failure with reduced ejection fraction.
    Cardiovasc Res. 2019 Jan 31. pii: 5305030. doi: 10.1093.
    PubMed    


  61. LIN H, Li Y, Zhu H, Wang Q, et al
    Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of beta-catenin.
    Cardiovasc Res. 2019 Jan 24. pii: 5300057. doi: 10.1093.
    PubMed     Abstract available


  62. MADONNA R, Van Laake LW, Botker HE, Davidson SM, et al
    ESC Working Group on Cellular Biology of the Heart: Tissue Engineering and Cell-Based Therapies for Cardiac Repair in Ischemic Heart Disease and Heart Failure.
    Cardiovasc Res. 2019 Jan 17. pii: 5292411. doi: 10.1093.
    PubMed     Abstract available


  63. NARUSE G, Kanamori H, Yoshida A, Minatoguchi S, et al
    The Intestine Responds to Heart Failure by Enhanced Mitochondrial Fusion through Glucagon-like Peptide-1 Signaling.
    Cardiovasc Res. 2019 Jan 10. pii: 5284909. doi: 10.1093.
    PubMed     Abstract available


  64. SINGH AP, Umbarkar P, Guo Y, Force T, et al
    Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regeneration.
    Cardiovasc Res. 2019;115:20-30.
    PubMed     Abstract available


  65. SURINKAEW S, Aflaki M, Takawale A, Chen Y, et al
    Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling.
    Cardiovasc Res. 2019;115:94-106.
    PubMed     Abstract available


  66. GRUND A, Szaroszyk M, Doppner JK, Malek Mohammadi M, et al
    A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Cardiovasc Res. 2019;115:71-82.
    PubMed     Abstract available


    December 2018
  67. ZHANG J, Sheng J, Dong L, Xu Y, et al
    Cardiomyocyte-specific loss of RMP causes myocardial dysfunction and heart failure.
    Cardiovasc Res. 2018 Dec 24. pii: 5258468. doi: 10.1093.
    PubMed     Abstract available


  68. MICKAEL C, Lee MH, Gu S, Graham BB, et al
    Comparing pulmonary hypertension severity between rat strains suggests right ventricle NK cells are protective.
    Cardiovasc Res. 2018 Dec 4. pii: 5229543. doi: 10.1093.
    PubMed    


    October 2018
  69. SUEN CM, Chaudhary KR, Deng Y, Jiang B, et al
    Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Cardiovasc Res. 2018 Oct 24. pii: 5144198. doi: 10.1093.
    PubMed     Abstract available


  70. ROE AT, Ruud M, Espe EK, Manfra O, et al
    Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression.
    Cardiovasc Res. 2018 Oct 23. pii: 5142689. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  71. SCHLOSS MJ, Horckmans M, Guillamat-Prats R, Hering D, et al
    2-arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.
    Cardiovasc Res. 2018 Sep 28. pii: 5115994. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  72. COPPINI R, Ferrantini C
    NaV1.8: a novel contributor to cardiac arrhythmogenesis in heart failure.
    Cardiovasc Res. 2018 Aug 29. pii: 5086354. doi: 10.1093.
    PubMed    


  73. BASTUG-OZEL Z, Wright PT, Kraft AE, Pavlovic D, et al
    Heart failure leads to altered beta2-adrenoceptor/cAMP dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain: Bastug et al. Phospholemman cAMP microdomain.
    Cardiovasc Res. 2018 Aug 27. pii: 5079901. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  74. POL AV, Gil A, Tromp J, Sillje HHW, et al
    OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction.
    Cardiovasc Res. 2018 Jul 19. pii: 5056075. doi: 10.1093.
    PubMed     Abstract available


  75. PANAHI M, Papanikolaou A, Torabi A, Zhang JG, et al
    Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.
    Cardiovasc Res. 2018 Jul 14. pii: 5054000. doi: 10.1093.
    PubMed     Abstract available


  76. DOBREV D, Fender AC, Wehrens XHT
    Pro-arrhythmic RyR2 channels in heart failure: do their localisation and mechanism of activation really matter?
    Cardiovasc Res. 2018 Jul 3. pii: 5048462. doi: 10.1093.
    PubMed    


    June 2018
  77. IDRES S, Perrin G, Domergue V, Lefebvre F, et al
    Contribution of BKCa channels to vascular tone regulation by PDE3 and PDE4 is lost in heart failure.
    Cardiovasc Res. 2018 Jun 23. pii: 5043286. doi: 10.1093.
    PubMed     Abstract available


  78. KARKKAINEN O, Tuomainen T, Mutikainen M, Lehtonen M, et al
    Heart specific PGC-1alpha deletion identifies metabolome of cardiac restricted metabolic heart failure.
    Cardiovasc Res. 2018 Jun 20. pii: 5040494. doi: 10.1093.
    PubMed     Abstract available


  79. NATTEL S
    Catheter ablation of atrial fibrillation and outcomes in heart failure patients: seeking the treasure in the CASTLE.
    Cardiovasc Res. 2018;114:e50-e52.
    PubMed    


    April 2018
  80. VAN DER ENDE MY, Said MA, van Veldhuisen DJ, Verweij N, et al
    Genome Wide Studies of Heart Failure and Endophenotypes: lessons learned and future directions.
    Cardiovasc Res. 2018 Apr 18. pii: 4975446. doi: 10.1093.
    PubMed     Abstract available


  81. DRIES E, Santiago DJ, Gilbert G, Lenaerts I, et al
    Hyperactive ryanodine receptors in human heart failure and ischemic cardiomyopathy reside outside of couplons.
    Cardiovasc Res. 2018 Apr 14. pii: 4970798. doi: 10.1093.
    PubMed     Abstract available


  82. BORGOGNONE A, Shantsila E, Worrall SM, Prompunt E, et al
    Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
    Cardiovasc Res. 2018 Apr 12. pii: 4969512. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  83. DE ROSA M, Gambardella J, Shu J, Santulli G, et al
    Dietary Fat is a Key Determinant in Balancing Mitochondrial Dynamics in Heart Failure: A Novel Mechanism Underlying the Obesity Paradox.
    Cardiovasc Res. 2018 Mar 22. pii: 4951453. doi: 10.1093.
    PubMed    


    November 2017
  84. FLORIJN BW, Bijkerk R, van der Veer E, van Zonneveld AJ, et al
    Gender and cardiovascular disease: Are sex-biased miRNA networks a driving force behind heart failure with preserved ejection fraction in women?
    Cardiovasc Res. 2017 Nov 24. pii: 4657087. doi: 10.1093.
    PubMed     Abstract available


  85. ZIEGLER KA, Ahles A, Wille T, Kerler J, et al
    Local sympathetic denervation attenuates myocardial inflammation and improves cardiac function after myocardial infarction in mice.
    Cardiovasc Res. 2017 Nov 24. pii: 4657089. doi: 10.1093.
    PubMed     Abstract available


    September 2017
  86. RIPPLINGER CM
    From drugs to devices and back again: chemical vagal nerve stimulation for the treatment of heart failure.
    Cardiovasc Res. 2017;113:1270-1272.
    PubMed    


    July 2017
  87. FRASER AG, Gillebert TC, Leite-Moreira AF
    Ventricular-arterial coupling in heart failure with preserved ejection fraction: the devil is in the details.
    Cardiovasc Res. 2017;113:844-846.
    PubMed    


    June 2017
  88. SCHOBESBERGER S, Wright P, Tokar S, Bhargava A, et al
    T-tubule remodelling disturbs localized beta2-adrenergic signalling in rat ventricular myocytes during the progression of heart failure.
    Cardiovasc Res. 2017;113:770-782.
    PubMed     Abstract available


    May 2017
  89. ABDURRACHIM D, Nabben M, Hoerr V, Kuhlmann MT, et al
    Diabetic db/db mice do not develop heart failure upon pressure overload: A longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
    Cardiovasc Res. 2017 May 26. doi: 10.1093.
    PubMed     Abstract available


  90. VILLALBA-ORERO M, Lopez-Olaneta MM, Gonzalez-Lopez E, Padron-Barthe L, et al
    Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.
    Cardiovasc Res. 2017 May 4. doi: 10.1093.
    PubMed     Abstract available


  91. GARROTT K, Dyavanapalli J, Cauley E, Kate Dwyer M, et al
    Chronic activation of hypothalamic oxytocin neurons improves cardiac function during left ventricular hypertrophy-induced heart failure.
    Cardiovasc Res. 2017 May 2. doi: 10.1093.
    PubMed     Abstract available


  92. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Cardiovasc Res. 2017;113:633-643.
    PubMed     Abstract available


  93. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017;113:598-608.
    PubMed     Abstract available


  94. HAUSENLOY DJ, Garcia-Dorado D, Botker HE, Davidson SM, et al
    Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
    Cardiovasc Res. 2017;113:564-585.
    PubMed     Abstract available


    April 2017
  95. CROSSMAN DJ, Shen X, Jullig M, Munro M, et al
    Increased collagen within the transverse tubules in human heart failure.
    Cardiovasc Res. 2017 Apr 20. doi: 10.1093.
    PubMed     Abstract available


  96. PEREZ DEL VILLAR C, Savvatis K, Lopez B, Kasner M, et al
    Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction.
    Cardiovasc Res. 2017 Apr 11. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  97. SATO T, Sato C, Kadowaki A, Watanabe H, et al
    ELABELA - APJ axis protects from pressure overload heart failure and Angiotensin II-induced cardiac damage.
    Cardiovasc Res. 2017 Mar 23. doi: 10.1093.
    PubMed     Abstract available


    February 2017
  98. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA Aptamer Can Prevent and Reverse Pressure Overload-Induced Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed    


  99. GRECO S, Zaccagnini G, Fuschi P, Voellenkle C, et al
    Increased Bace1-As Long Noncoding Rna And beta-Amyloid Levels In Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed    


  100. ELIA L, Quintavalle M, Condorelli G
    Circular RNAs and heart failure: new players for an old disease.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed    


    January 2017
  101. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017 Jan 20. pii: cvw245. doi: 10.1093.
    PubMed     Abstract available


    November 2016
  102. LI L, Li J, Drum BM, Chen Y, et al
    Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Cardiovasc Res. 2016.
    PubMed     Abstract available


    July 2016
  103. LIU L, An X, Li Z, Song Y, et al
    The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;111:56-65.
    PubMed     Abstract available


  104. SCHEID LM, Mosqueira M, Hein S, Kossack M, et al
    Essential light chain S195 phosphorylation is required for cardiac adaptation under physical stress.
    Cardiovasc Res. 2016;111:44-55.
    PubMed     Abstract available


    June 2016
  105. HILLE S, Dierck F, Kuhl C, Sosna J, et al
    Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
    Cardiovasc Res. 2016;110:381-94.
    PubMed     Abstract available


    May 2016
  106. KOOIJ V, Viswanathan MC, Lee DI, Rainer PP, et al
    Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;110:238-48.
    PubMed     Abstract available


    January 2016
  107. GOH KY, Qu J, Hong H, Liu T, et al
    Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes.
    Cardiovasc Res. 2016;109:79-89.
    PubMed     Abstract available


    December 2015
  108. KUMAGAI S, Nakayama H, Fujimoto M, Honda H, et al
    Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction.
    Cardiovasc Res. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: